Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Fever × trametinib × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 11 Multiple Myeloma 5 Carcinoma, Non-Small-Cell Lung 5 Neurofibromatosis 1 4 Neoplasm Metastasis 4 Lymphoma 4 Hematologic Neoplasms 4 Glioma 4 Thyroid Neoplasms 3 Thyroid Carcinoma, Anaplastic 3 Neurofibroma, Plexiform 3 Colorectal Neoplasms 3 Brain Neoplasms 3 Pancreatic Neoplasms 2 Glioblastoma 2 Astrocytoma 2 Uveal Melanoma 1 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1 Thyroid Cancer, Papillary 1 Solid Tumors, KRAS Mutation; SOS1 1 Sarcoma 1 Prostatic Neoplasms 1 Oligodendroglioma 1 Neurocytoma 1 Neuroblastoma 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Histiocytosis, Langerhans-Cell 1 Ganglioneuroma 1

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01972347 2025-12-16

Neo Combi

Melanoma Institute Australia

Phase 2 Active not recruiting

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡